Balyasny Asset Management
CC icon

Balyasny Asset Management’s Chemours CC Stock Holding History

Balyasny Asset Management’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,078,300
Closed -$43.7M – 1431
2018
Q3 		$43.7M Buy
+1,078,300
New +$47.2M 0.2% 129
2017
Q4 		– Sell
-210,000
Closed -$10.6M – 2073
2017
Q3 		$10.6M Hold
210,000
– – 0.04% 482
2017
Q2 		$7.96M Buy
+210,000
New +$8.28M 0.03% 609

Other funds holding CC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
WHCM
Wolf Hill Capital Management Greenwich, Connecticut $1.03B AUM 80.44% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Balyasny Asset Management's CC Position: Q1 2026 in Review

Balyasny Asset Management sold out of Chemours (CC) in Q1 2026, closing a stake of 710,854 shares — an estimated $8.38M sold.

Balyasny Asset Management first reported a position in CC in Q1 2017 and held it in 29 quarters. The position peaked at $39.5M in Q4 2017. 448 funds tracked by Wall St. Rank hold CC as of Q1 2026.

  • Balyasny Asset Management reported no remaining Chemours position as of Q1 2026 after selling out during the quarter.
  • Balyasny Asset Management sold 710,854 Chemours shares in Q1 2026, an estimated $8.38M.
  • Balyasny Asset Management first reported a position in Chemours in Q1 2017 and held it in 29 quarters.
  • Balyasny Asset Management's Chemours position peaked at $39.5M in Q4 2017.
  • 448 funds tracked by Wall St. Rank held Chemours as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.